Green Bioactives secures pre-seed round investment
Green Bioactives uses a plant cell-based biomanufacturing platform to produce biomolecules and cell extracts for the cosmetic, pharmaceutical, food and agricultural markets.
The biotechnology start-up recently secured a pre-seed round investment from a series of London-based, high-net worth individuals, introduced to Green Bioactives through Ascensions VC syndicate. Before closing its ongoing seed investment round, Green Bioactives plans to leverage this pre-seed funding to continue to build on and secure IP, and to attract customers for its platform across its target markets.
Published online on June 6th, 2022.